News about "Aesthetic medicine"

Caliway Biopharmaceuticals Receives US FDA Clearance for Global Phase 3 Trial of Fat Reduction Drug CBL-514

Caliway Biopharmaceuticals Receives US FDA Clearance for Global Phase 3 Trial of Fat Reduction Drug CBL-514

Caliway Biopharmaceuticals secures US FDA IND clearance for CBL-0302, a global phase 3 clinical trial evaluating CBL-514 for non-surgical abdominal fat reduction.

Aesthetic Medicine | 28/05/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members